BRAIN Biotech AG (LON:0RFI)
1.990
0.00 (0.00%)
At close: Jul 4, 2025
BRAIN Biotech AG Revenue
BRAIN Biotech AG had revenue of 12.36M EUR in the quarter ending March 31, 2025, a decrease of -15.68%. This brings the company's revenue in the last twelve months to 53.52M, down -4.89% year-over-year. In the fiscal year ending September 30, 2024, BRAIN Biotech AG had annual revenue of 55.50M, down -1.29%.
Revenue (ttm)
53.52M EUR
Revenue Growth
-4.89%
P/S Ratio
0.79
Revenue / Employee
168.29K EUR
Employees
318
Market Cap
35.49M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 55.50M | -726.00K | -1.29% |
Sep 30, 2023 | 56.23M | 5.93M | 11.79% |
Sep 30, 2022 | 50.30M | 11.07M | 28.23% |
Sep 30, 2021 | 39.22M | 158.00K | 0.40% |
Sep 30, 2020 | 39.06M | -982.00K | -2.45% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
Rolls-Royce Holdings | 18.91B |
British American Tobacco p.l.c. | 25.87B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |